retatrutide nonalcoholic steatohepatitis trial fatty liver study disease nash Trial comparing time-restricted eating (TRE) vs. basic Calorie retatrutide fatty liver study 🧬 – retatrutide nonalcoholic fatty liver disease

Drawing a conclusion that subcutaneous semaglutide is associated with worsening of DR from this paper alone is thus premature

Your body does its deepest detoxification work during sleep

Others may benefit from the added metabolic support of a dual-action option, such as tirzepatide

The overall incidence of reported adverse reactions of hypoglycemia in patients with type 2 diabetes inadequately controlled on diet and exercise was 0.6% in patients given placebo, 0.6% in patients given sitagliptin alone, 0.8% in patients given metformin immediate-release alone, and 1.6% in patients given sitagliptin in combination with metformin immediate-release

And so many of our patients, so many people with obesity, that's exactly what they experience

Im personally most interested [in] liver disease because a lot of my patients dont just have obesity, they have fatty liver, elevated liver enzymes, insulin resistance, and visceral fat, he said